Diffusion Pharmaceutical LLC
  • Email
  • Facebook
  • Twitter
  • Rss
  • Home
  • About
    • Introduction
    • Executive Summary
    • Management
    • Board of Directors
    • Investors
      • Investor Information Log-In
      • Potential Investor Registration
    • Intellectual Property
    • Useful Links
  • Cancer Treatment
    • Overview/The Problem
    • Treatment Resistance in Cancer
    • Tumor Sensitization and TSC
    • Preclinical Results
  • Clinical Trials
    • Clinical Trials Overview
  • Publications
    • Cancer
    • Cardiovascular and Stroke
    • Hemorrhagic Shock
    • Other
  • Programs
    • Program Overview
    • Glioblastoma Program
    • Brain Metastasis Program
    • Other Indications For TSC
  • News
    • Press Releases
    • Subscribe
  • Contact
    • Contact
    • Directions

Publications

  • Cancer
  • Cardiovascular and Stroke
  • Hemorrhagic Shock
  • Other

Cardiovascular and Stroke

Hiatt W, Barz K, Gainer J, Mohler E.  Evaluation of trans sodium crocetinate on safety and exercise performance in patients with peripheral artery disease and intermittent claudication.  Circulation. 2010; 122:A12341.

 Mohler ER III, Gainer J, Whitten K, Eraso LH, Thanaporn PK,  Bauer T.  Evaluation of trans sodium crocetinate on safety and exercise performance in patients with peripheral artery disease and intermittent claudication. Vascular Medicine. 2011; 16:346-353.

Lapchak P.  Efficacy and safety profile of the carotenoid trans sodium crocetinate administered to rabbits following multiple infarct ischemic strokes: a combination therapy study with tissue plasminogen activator. Brain Res. 2010; 1309:136-145.

Manabe H, Okonkwo DO, Gainer JL, Clarke RH, Lee KS.  Protection against focal ischemic injury to the brain by trans-sodium crocetinate. J Neurosurg. 2010; 113:802-809.

  • Office: 434-220-0718
  • Contact Us
    • Facebook
    • Email
© 2012 Diffusion Pharmaceutical LLC


Charlottesville SEO